<SEC-DOCUMENT>0001415889-25-020805-index.html : 20250731
<SEC-HEADER>0001415889-25-020805.hdr.sgml : 20250731
<ACCEPTANCE-DATETIME>20250731210514
ACCESSION NUMBER:		0001415889-25-020805
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250729
FILED AS OF DATE:		20250731
DATE AS OF CHANGE:		20250731

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hardiman Roy C.
		CENTRAL INDEX KEY:			0001506218
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42143
		FILM NUMBER:		251173397

	MAIL ADDRESS:	
		STREET 1:		C/O ALUMIS INC.
		STREET 2:		280 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALUMIS INC.
		CENTRAL INDEX KEY:			0001847367
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		280 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-231-6625

	MAIL ADDRESS:	
		STREET 1:		280 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ESKER THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20230427

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FL2021-001, Inc.
		DATE OF NAME CHANGE:	20210222
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-07312025_090710.xml
<TEXT>
Document 1 - file: form4-07312025_090710.html

Document 1 - RAW XML: form4-07312025_090710.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ex24-07312025_090710.htm
<TEXT>
Document 2 - file: ex24-07312025_090710.htm

</DOCUMENT>
</SEC-DOCUMENT>